Table 1.
Somatic mutations identified in the primary tumor, metastasis and plasma.
Gene | Chr: position | Ref allele | Mut allele | Codon change | Protein change | Variant type | VAF% | ||
---|---|---|---|---|---|---|---|---|---|
Tumor | Metastasis | PS1 | |||||||
KRAS | chr12: 25398284 | C | A | c.35G>T | p.Gly12Val | Missense | 43.28 | 35.86 | 23.23 |
TP53 | chr17: 7578406 | C | T | c.524G>A | p.Arg175His | Missense | 80.23 | 61.35 | 28.27 |
RB1 | chr13: 49033902 | T | C | c.2039T>C | p.Ile680Thr | Missense | 11.11 | 1.08 | ND |
ALK | chr2: 29443666 | C | T | c.3551G>A | p.Gly1184Glu | Missense | 25.89 | ND | ND |
ERBB2 | chr17: 37881388 | A | G | c.2580A>G | p.Lys860Lys | Synonymous | 19.66 | ND | ND |
Chr, chromosome; Ref, reference allele; Mut, mutated allele; VAF, variant allele frequency; PS1, plasma sample #1 (pretreatment) ND, not detected.